Revenue
2022
2023
2024
2025
SBC Medical Group Holdings Inc (SBC)
Price$4.48Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $173.6M | $205.4M | $193.5M | $174.2M |
| Gross profit | $127.3M | $156.1M | $137.3M | $114.8M |
| Gross margin | 73.32% | 75.97% | 70.94% | 65.94% |
| Operating expenses | $59.8M | $85.7M | $66.6M | $382,051 |
| Operating income | $67.5M | $70.3M | $70.7M | −$543,695 |
| Operating margin | 38.87% | 34.23% | 36.51% | −0.31% |
| EBITDA | $70.2M | $74.1M | $82.9M | $29.6M |
| EBITDA margin | 40.42% | 36.07% | 42.84% | 17.02% |
| Net income | $51.0M | $46.6M | $39.4M | $552,813 |
| Net profit margin | 29.37% | 22.69% | 20.34% | 0.32% |
| Basic EPSper basic share | $0.50 | $0.48 | $0.42 | $0.06 |
| Diluted EPSper diluted share | $0.50 | $0.48 | $0.42 | $0.06 |
Owners
Reported shareholders
≈82.57%of listed shares
Aikawa Yoshiyuki84.7M shares · Apr 28, 2026
View holders
| Holder | % owned |
|---|---|
Aikawa Yoshiyuki | ≈82.57%84.7M shares |
Lumbard & Kellner, LLC | 1.68%1.73M shares |
BlackRock, Inc. | 0.90%924K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.42%427.86K shares |
CITADEL ADVISORS LLC | 0.14%144.72K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.13%135.78K shares |
NORTHERN TRUST CORP | 0.13%131.2K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.13%128.3K shares |
Hillsdale Investment Management Inc. | 0.12%124.8K shares |
SEGALL BRYANT & HAMILL, LLC | 0.08%81.31K shares |
VANGUARD FIDUCIARY TRUST CO | 0.06%66.28K shares |
SBI Securities Co., Ltd. | 0.05%49.44K shares |
STATE STREET CORP | 0.05%49.24K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.05%46.86K shares |
Mariner, LLC | 0.03%33.75K shares |
Bank of New York Mellon Corp | 0.03%26.99K shares |
Nuveen, LLC | 0.02%25.38K shares |
AQR CAPITAL MANAGEMENT LLC | 0.02%24.1K shares |
Central Pacific Bank - Trust Division | 0.02%24K shares |
TWO SIGMA SECURITIES, LLC | 0.02%21.49K shares |
Percentages use 102.58M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 28, 2026Form 4 | Aikawa YoshiyukiChairman and CEO | SellCommon Stock | 465.0K | $3.02 | $1.40M | 78.84M |
| Apr 21, 2026Form 4 | Aikawa YoshiyukiChairman and CEO | SellCommon Stock | 3.10M | $3.02 | $9.36M | 79.30M |
| Mar 6, 2026Form 4 | Aikawa YoshiyukiChairman and CEO | SellCommon Stock · indirect | 4.42M | $2.12 | $9.38M | 861.6K |
| Sep 19, 2024Form 4 | ZUU Funders Co. Ltd. +3TenPercentOwner | SellCommon Stock, par value $0.0001 per share · indirect | 6.2K | $7.34 | $45.5K | 2.92M |
| Aug 22, 2024Form 4 | ZUU Target Fund for SBC Medical Group HD Investment Partnership +3TenPercentOwner | BuyClass A Common Stock · indirect | 8.4K | $10.51 | $88.3K | 1.42M |